Seirei Hospice, Seirei Mikatahara General Hospital, 3453 Mikatahara-cho, Kita-ku, Hamamatsu, Shizuoka, 433-8558, Japan.
Division of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Support Care Cancer. 2018 Jun;26(6):1763-1771. doi: 10.1007/s00520-017-4011-2. Epub 2017 Dec 14.
This study investigated the effect of two types of palliative sedation defined using intervention protocols: proportional and deep sedation.
We retrospectively analyzed prospectively recorded data of consecutive cancer patients who received the continuous infusion of midazolam in a palliative care unit. Attending physicians chose the sedation protocol based on each patient's wish, symptom severity, prognosis, and refractoriness of suffering. The primary endpoint was a treatment goal achievement at 4 h: in proportional sedation, the achievement of symptom relief (Support Team Assessment Schedule (STAS) ≤ 1) and absence of agitation (modified Richmond Agitation-Sedation Scale (RASS) ≤ 0) and in deep sedation, the achievement of deep sedation (RASS ≤ - 4). Secondary endpoints included mean scores of STAS and RASS, deep sedation as a result, and adverse events.
Among 398 patients who died during the period, 32 received proportional and 18 received deep sedation. The treatment goal achievement rate was 68.8% (22/32, 95% confidence interval 52.7-84.9) in the proportional sedation group vs. 83.3% (15/18, 66.1-100) in the deep sedation group. STAS decreased from 3.8 to 0.8 with proportional sedation at 4 h vs. 3.7 to 0.3 with deep sedation; RASS decreased from + 1.2 to - 1.7 vs. + 1.4 to - 3.7, respectively. Deep sedation was needed as a result in 31.3% (10/32) of the proportional sedation group. No fatal events that were considered as probably or definitely related to the intervention occurred.
The two types of intervention protocol well reflected the treatment intention and expected outcomes. Further, large-scale cohort studies are promising.
本研究调查了使用干预方案定义的两种姑息性镇静作用的效果:比例性镇静和深度镇静。
我们回顾性分析了连续在姑息治疗病房接受咪达唑仑持续输注的癌症患者的前瞻性记录数据。主治医生根据每位患者的意愿、症状严重程度、预后和痛苦的耐药性选择镇静方案。主要终点是 4 小时时的治疗目标实现:在比例性镇静中,达到症状缓解(支持团队评估量表(STAS)≤1)和无激越(改良 Richmond 激越-镇静量表(RASS)≤0),在深度镇静中,达到深度镇静(RASS ≤-4)。次要终点包括 STAS 和 RASS 的平均评分、深度镇静的结果和不良事件。
在研究期间死亡的 398 名患者中,32 名接受了比例性镇静,18 名接受了深度镇静。比例性镇静组的治疗目标实现率为 68.8%(22/32,95%置信区间 52.7-84.9),深度镇静组为 83.3%(15/18,66.1-100)。比例性镇静在 4 小时时 STAS 从 3.8 降至 0.8,而深度镇静从 3.7 降至 0.3;RASS 分别从+1.2 降至-1.7 和从+1.4 降至-3.7。在比例性镇静组中,有 31.3%(10/32)需要深度镇静。没有发生被认为可能或肯定与干预相关的致命事件。
这两种干预方案很好地反映了治疗意图和预期结果。此外,大规模队列研究很有前途。